Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome Using an "N of 1" Study Design

NCT07150013 is registered in ClinicalTrials.gov with Unravel Biosciences, Inc. as lead sponsor.

NCT NCT07150013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07150013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome Using an "N of 1" Study Design
Lead sponsor
Unravel Biosciences, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
March 15, 2026
Completion date
March 15, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome